ResMed to Report Fourth Quarter Fiscal 2023 Earnings on August 3, 2023
06 juil. 2023 16h05 HE
|
ResMed Inc.
SAN DIEGO, July 06, 2023 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the fourth quarter of fiscal year 2023 on...
ResMed Acquires Somnoware, a Leader in Digital Sleep and Respiratory Care Diagnostics Software
05 juil. 2023 16h05 HE
|
ResMed Inc.
Expands ResMed’s sleep management software solution, will help sleep labs and physicians more efficiently guide patients into and through diagnosis to long-term treatmentDiagnostic management platform...
PAP Adherence Lowers ER Visits 24-36% in 1 Year for People with Sleep Apnea and Heart Failure: ResMed Studies Presented at SLEEP
08 juin 2023 09h00 HE
|
ResMed Inc.
The studies also showed 18-40% lower costs incurred from ER visits and hospitalizations after 1 year for PAP-adherent OSA patients with diastolic and systolic heart failure, respectivelyA third study...
ResMed Announces Participation in the Goldman Sachs 44th Annual Global Healthcare Conference
05 juin 2023 16h05 HE
|
ResMed Inc.
SAN DIEGO, June 05, 2023 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Rob Douglas, president and chief operating officer, will participate in a fireside chat at the Goldman Sachs...
3 World-Renowned Sleep Apnea Experts Present New Benefits of PAP Therapies at ATS 2023
25 mai 2023 09h00 HE
|
ResMed Inc.
France’s Jean-Louis Pépin and Germany’s Holger Woehrle presented studies in which treating OSA with CPAP lowered all-cause mortality for PAP vs. non-PAP users with OSAGermany’s Michael Arzt presented...
ResMed Appoints Michael Rider its Next Global General Counsel, Dawn Haake its First Chief Quality Officer
02 mai 2023 16h05 HE
|
ResMed Inc.
Rider and Haake, both internal promotions, joined ResMed’s executive team on May 1Rider, currently Senior Vice President, Deputy Global General Counsel will succeed retiring Chief Administrative...
ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2023
27 avr. 2023 16h05 HE
|
ResMed Inc.
Note: A webcast of ResMed’s conference call will be available at 4:30 p.m. ET today at http://investor.resmed.com SAN DIEGO, April 27, 2023 (GLOBE NEWSWIRE) -- ResMed Inc. (NYSE: RMD, ASX: RMD)...
ResMed to Report Third Quarter Fiscal 2023 Earnings on April 27, 2023
06 avr. 2023 16h05 HE
|
ResMed Inc.
SAN DIEGO, April 06, 2023 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the third quarter of fiscal year 2023 on...
ResMed Chief Administrative Officer and Global General Counsel to Retire
30 mars 2023 16h05 HE
|
ResMed Inc.
ResMed to conduct an internal search for a successor general counselAmy Wakeham appointed Chief Communications and Investor Relations Officer, will join ResMed’s executive leadership team SAN DIEGO,...
ResMed Announces Participation in the 2023 KeyBanc Life Sciences & MedTech Investor Forum
15 mars 2023 16h19 HE
|
ResMed Inc.
SAN DIEGO, March 15, 2023 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Rob Douglas, president and chief operating officer, will join a fireside chat at the 2023 KeyBanc Life...